These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6182250)

  • 1. Comparison between circulating interferon and drug levels following administration of 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP) to different animal species.
    Hamilton RD; Wynalda MA; Fitzpatrick FA; Teagarden DL; Hamdy AH; Snider BG; Weed SD; Stringfellow DA
    J Interferon Res; 1982; 2(3):317-27. PubMed ID: 6182250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the antitumor activities of pyrimidinone-interferon inducers. I. Effect against artificial and spontaneous lung metastases of murine tumors.
    Milas L; Hersh EM; Stringfellow DA; Hunter N
    J Natl Cancer Inst; 1982 Jan; 68(1):139-45. PubMed ID: 6172625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP), an oral interferon inducer, in cancer patients.
    Rios A; Stringfellow DA; Fitzpatrick FA; Reele SB; Gutknecht GD; Hersh EM
    J Biol Response Mod; 1986 Aug; 5(4):330-8. PubMed ID: 2426417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feline interferon response to 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166).
    Stringfellow DA; Weed Sd
    Am J Vet Res; 1977 Dec; 38(12):1963-7. PubMed ID: 596695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon counteracts pyrimidinone-induced hyporeactivity and the combined treatment has antitumor effect in mice.
    Oku T; Imanishi J; Kishida T
    Gan; 1984 Jul; 75(7):631-40. PubMed ID: 6205930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine retroviral disease-enhancing effects of a pyrimidinone immunomodulator.
    Warren RP; Morrey JD; Burger RA; Okleberry KM; Sidwell RW
    Antiviral Res; 1992 Sep; 19(3):233-45. PubMed ID: 1444328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine induction in mice by the immunomodulator imiquimod.
    Reiter MJ; Testerman TL; Miller RL; Weeks CE; Tomai MA
    J Leukoc Biol; 1994 Feb; 55(2):234-40. PubMed ID: 7507969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the interferon-inducer ABPP on colon cancer in rats; importance of tumor load and tumor site.
    Eggermont AM; Marquet RL; de Bruin RW; Jeekel J
    Cancer Immunol Immunother; 1986; 22(3):217-20. PubMed ID: 2942251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination immunotherapy of murine transitional cell cancer using BCG and an interferon-inducing pyrimidinone.
    Sarosdy MF; Kierum CA
    J Urol; 1989 Nov; 142(5):1376-9. PubMed ID: 2810534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon induction by 5-halo-6-phenyl pyrimidinones.
    Stringfellow DA; Vanderberg HC; Weed SD
    J Interferon Res; 1980; 1(1):1-14. PubMed ID: 6286802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of murine interferon by a substituted pyrimidine.
    Nichol FR; Weed SD; Underwood GE
    Antimicrob Agents Chemother; 1976 Mar; 9(3):433-9. PubMed ID: 176934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment of colon adenocarcinoma in rats with tumor necrosis factor and the interferon inducer ABPP.
    Marquet RL; Eggermont AM; de Bruin RW; Fiers W; Jeekel J
    J Interferon Res; 1988 Jun; 8(3):319-23. PubMed ID: 3411161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of experimental atherosclerosis in rabbits by interferon-inducing agents.
    Kuo PT; Wilson AC; Goldstein RC; Schaub RG
    J Am Coll Cardiol; 1984 Jan; 3(1):129-34. PubMed ID: 6197432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of 7,12-dimethylbenz(alpha)anthracene (DMBA) induced rat mammary tumors by 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP).
    Chang AY; Chuang C; Pandya KJ; Wierenga W
    J Biol Response Mod; 1986 Apr; 5(2):112-6. PubMed ID: 2426416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection from carcinogen-induced murine bladder carcinoma by interferons and an oral interferon-inducing pyrimidinone, bropirimine.
    Borden EC; Sidky YA; Ertürk E; Wierenga W; Bryan GT
    Cancer Res; 1990 Feb; 50(4):1071-4. PubMed ID: 2297754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of an interferon inducer bropirimine on bleomycin-induced lung fibrosis in hamsters.
    Zia S; Hyde DM; Giri SN
    Pharmacol Toxicol; 1992 Jul; 71(1):11-8. PubMed ID: 1381833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of natural killer cells in two random-bred strains of athymic rats by interferon-inducing pyrimidinone.
    Lotzová E; Savary CA; Khan A; Stringfellow DA
    J Immunol; 1984 May; 132(5):2566-70. PubMed ID: 6201549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and initial characterization of guinea pig interferon.
    Warfel AH; Stewart WE
    J Interferon Res; 1980; 1(1):19-22. PubMed ID: 6180041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effects of oral administration of an interferon-inducing pyrimidinone, Bropirimine, on murine renal-cell carcinoma.
    Fujioka T; Ishikura K; Hasegawa M; Ogyu K; Matsushita Y; Sato M; Sato F; Aoki H; Kubo T
    Cancer Chemother Pharmacol; 1995; 36(1):7-12. PubMed ID: 7536641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the antitumor activities of pyrimidinone-interferon inducers. Part 2. Potentiation of antitumor resistance mechanisms.
    Milas L; Hunter N; Ito H; Lotzová E; Stringfellow DA
    Clin Exp Metastasis; 1983; 1(3):213-22. PubMed ID: 6336272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.